FDA cleared Meridian Bioscience’s illumingene® molecular diagnostic test for Group A Streptococcus pharyngitis. The test, carried out on the illumigene molecular diagnostic platform, uses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback